STERIS closes sale of Renal Care business to Evoqua Water Technologies for $196M

STERIS plc

Closed sale of Renal Care business to Evoqua Water Technologies on Jan 3, 2022 for ~$196M cash.
Proceeds will be used to pay down bank debt.
Renal Care was acquired as part of the Cantel Medical transaction (June 2021).
Business was primarily integrated into STERIS's Healthcare segment.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.